Tokyo, April 27, 2016 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced that its subsidiary, Astellas US LLC is co-sponsoring the C3 (Changing Cancer Care) Prize with the World Medical Innovation Forum, Stanford Medicine X and MATTER.
The C3 Prize is a challenge designed to inspire non-medicine innovations that improve cancer care. While the C3 Prize selection will be judged in the United States according to the official rules, the application process is open to other markets on its official website.
The regulations and laws of the United States apply to the C3 Prize. For more information, visit www.C3Prize.com.
Through the C3 Prize, Astellas commits to providing solutions for patients, families and caregivers who are living with cancer, and improve cancer care.
###
